eyeFlow, Inc.

eyeFlow, Inc is an Irvine, California-based medical device company pioneering innovative solutions for glaucoma treatment. We are dedicated to combating the world’s leading cause of irreversible blindness, affecting 100 million people globally. Our core service is the development of a micro-invasive device – the eyeFlow microstent – designed to replace glaucoma drop medication therapy through mechanical stenting paired with sustained, localized drug delivery.

eyeFlow represents a significant advancement in Micro Invasive Glaucoma Surgery (MIGS), offering a more accessible and intuitive procedure. We operate within the $5.7 billion glaucoma treatment market, and our device has demonstrated promising results in early pre-clinical trials, garnering praise from leading ophthalmologists like Dr. Arsham Sheybani and Dr. Iqbal Ike K. Ahmed.

The eyeFlow team combines over 150 years of experience in ophthalmological device development, clinical practice, and business strategy. We are committed to preserving vision and offer unique investment opportunities to those who share our mission.